AzTrials
AzTrials

TeenagersCALYPSONCT07440134

Visual and Postural Behavior in Myopic and Non-Myopic Teenagers

A study testing Ophtalmic measurements and Visuo-postual measurements in people with Teenagers and Myopia, run by Essilor International at 1 site in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this observational study is to learn whether different types of eyeglasses prescription and different types of lenses change how close teenagers hold objects when looking at them up close. Read more about this study

Who is it for?
Ages 12 to 17 yearsHealthy volunteers can take part
Conditions the study is for
Teenagers, Myopia
What is being tested?
Ophtalmic measurements and Visuo-postual measurements
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
1 siteFrance
Study dates
3 Apr 2026to May 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 to 17 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Volunteer adolescent, fluent in French, able to follow protocol and read and write
  • Aged between 12 and 17 years and 6 months
  • Adolescent with no history, according to the participant and/or their legal representatives, of any pathology, deficit, or disorder that could interfere with visual or cognitive functions.
  • If the subject wears glasses, they must have an ophthalmic prescription dated within the last year, certifying that a consultation was carried out during the previous year
  • If the subject wears Essilor® Stellest® 1.0 lenses, they must have worn them for at least two (2) consecutive months prior to inclusion in the study.
  • If the subject is nearsighted: -6.5D ≤ equivalent sphere ≤ -0.5D with usual correction
  • If the subject is not nearsighted: -0.5 < equivalent sphere ≤ +2.5

Who cannot join

  • Age < 12 years
  • Age > 17 years and 6 months
  • Pregnant or breastfeeding women (Article L1121-5)
  • Persons (legal representatives or subjects) deprived of their liberty by a judicial or administrative decision and persons hospitalized without consent pursuant to Articles L. 3212-1 and L. 3213-1 who are not covered by the provisions of Article L. 1121-8 and persons admitted to a health or social care facility for purposes other than research
  • Participants who are currently excluded from another study
  • All categories of persons who are particularly protected under French law are excluded from this research (Articles L1121-5 to L1121-9 of the Public Health Code)
Show all 15Show fewer
  • Declared neurological deficit, in particular a history of epileptic pathology or sensorimotor coordination disorders, vestibular or cerebellar pathology (e.g., balance disorders)
  • Severe declared eye disease involving loss of visual field, such as glaucoma, involving loss of acuity and severe discomfort in low-light or overly bright environments, such as retinitis pigmentosa, or declared and treated dry eye syndrome.
  • Gougerot-Sjögren syndrome or declared dry eye syndrome
  • Declared aphakia or pseudophakia (intraocular implant)
  • Declared systemic pathology, medical treatment, or medication with an effect on vision
  • People with declared muscle paralysis
  • Binocular vision problems such as amblyopia, strabismus, or nystagmus
  • Children of employees or employees of Essilor International, Luxottica, GrandVision, and their subsidiaries
  • Individuals who have undergone previous refractive surgery, have a history of strabismus surgery, or have a history of any type of eye surgery

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

David Rio, Phd contact

+33(0)155964840

riod@essilor.fr

Sébastien Fricker contact

+33155964970

frickers@essilor.fr

France1 site, 1 recruiting
  • Paris Bastille

    Paris, 75012

    David Rio, Main investigator, +33(0)155964840, riod@essilor.fr

    Recruiting

Other trials in France

About this study

Official title: Comportement Visuo-postural Des Adolescents Myopes et Non Myopes (CALYPSO)

The goal of this observational study is to learn whether different types of eyeglasses prescription and different types of lenses change how close teenagers hold objects when looking at them up close. The study includes adolescents who are non-myopic and adolescents who are myopic and wear either single-vision lenses or lenses slowing down myopia progression.

The main questions it aims to answer are:

Read more

Do teenagers in these three groups use different average working distances (eye-to-object distance) during everyday tasks?

Does wearing Essilor® Stellest® lenses change working distance compared with wearing single-vision lenses?

Researchers will compare the three groups to see if their working distances differ.

Participants will:

Complete an initial optometric eye examination.

Come for a second visit where they perform everyday activities while wearing a motion-capture system that measures how they move and how far they hold objects.

Conditions
Teenagers, Myopia
Being tested
Ophtalmic measurements, Visuo-postual measurements
Keywords
Myopia, Ophthalmological measurements
Medical subject headings
Myopia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Ophtalmic measurementsDevice

    Participants will undergo a standard ophthalmic examination during the initial visit. All procedures are non-invasive, non-ionising, and conducted using devices routinely employed in clinical ophthalmic practice.

  • Visuo-postual measurementsBehavioural

    The behavioral part of the study consists of a set of tasks designed to assess eye movements and visual behavior in both controlled and ecological conditions. Participants perform everyday activities while eye movements and body motion are recorded using an eye tracker and motion capture systems.

Study groups in NCT07440134
Study groupRoleWhat they receive
non-myopic teenagersExperimentalNot described
Receives: Device: Ophtalmic measurements; Behavioral: Visuo-postual measurements
myopic teenagers wearing Essilor® Stellest® lensesExperimentalNot described
Receives: Device: Ophtalmic measurements; Behavioral: Visuo-postual measurements
myopic teenagers wearing single vision lensesExperimentalWorn lenses do not have a myopia-control effect
Receives: Device: Ophtalmic measurements; Behavioral: Visuo-postual measurements

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Working distance using motion capture system

    Quantitative assessment of working distance in meters during near vision tasks using a motion capture system

    Measured: From enrollment to 3 months after enrollment

Secondary outcomes (3)
  1. Gaze behavior during near vision tasks accessed with an eye-tracking system

    Assessment of eye movements (spatial coordinates) during near vision tasks

    Measured: From enrollment to 3 months after enrollment

  2. Posture, eye-head coordination during near-vision tasks (with motion capture system)

    Quantitative evaluation of postural behavior (spatial coordinates of body parts) while performing near vision tasks.

    Measured: From enrollment to 3 months after enrollment

  3. Correlation coefficient (R2) between optometric profile and near-vision behavior

    Statistical analysis of the association between participants' optometric characteristics and their near vision behavioral patterns.

    Measured: From enrollment to 3 months after enrollment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Feb 2026
  2. Study start3 Apr 2026
  3. Primary completionMay 2027 (estimated)
  4. Study completionMay 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07440134
Sponsor's protocol ID
WS10477
Other IDs
2025-A02517-42
Acronym
CALYPSO
Status last verified
Jan 2026
First submitted
12 Feb 2026
Last updated
17 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Ophtalmic measurements and Visuo-postual measurements in people with Teenagers and Myopia, run by Essilor International at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 15 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 17 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact David Rio, Phd (+33(0)155964840, riod@essilor.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Working distance using motion capture system (time frame: From enrollment to 3 months after enrollment). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in